Effect of cupping on diabetes type II

Not Applicable

• Conditions: Diabetes Mellitus.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT2013041513019N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

No history of consumption of alcohol, Cigarette, Antioxidant; No suffering from special diseases like Cancer, Thyroid gland disorders, Cardiovascular diseases, Respiratory diseases, Anemia, Coagulation disorders; Menopause period;
Exclusion criteria: Creatinine above 2.5; Hemoglobin below 10 mg/dl; Vitamins and complements consumption; carbohydrates consumption;

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin A1C. Timepoint: Before & After treatment. Method of measurement: Eliza with Pars Azmon Kit.;Fasting Blood Sudar. Timepoint: Before & After treatment. Method of measurement: Eliza with Pars Azmon Kit.;Blood sugar 2 hours after fasting. Timepoint: Before & After treatment. Method of measurement: Eliza with Pars Azmon Kit.

Secondary Outcome Measures

Name	Time	Method
Triglycerid. Timepoint: Before & after treatment. Method of measurement: Eliza with Pars Azmon Kit.;Cholesterol. Timepoint: Before & after treatment. Method of measurement: Eliza with Pars Azmon Kit.;Low Density Lipoprotein. Timepoint: Before & after treatment. Method of measurement: Eliza with Pars Azmon Kit.;Lipid peroxidation. Timepoint: Before & after treatment. Method of measurement: TBA (Thio Barbituric Acid).;Serum total Antioxidants. Timepoint: Before and after. Method of measurement: FRAP test.